New Sanctions Imposed in Pradaxa Multidistrict Litigation for Abuses During Discovery Phase: Now, AttorneyOne Can Provide Advice

According to a Court Order filed in March 13, new sanctions were imposed on Boehringer Ingelheim for Pradaxa Multidistrict Litigation discovery abuses. In light of this news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Pradaxa side effects.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Pradaxa: serious adverse events

Pradaxa: serious adverse events

according to unsealed court filings, Boehringer didn’t share with the FDA an analysis showing a higher death rate from Pradaxa bleeding

San Diego, CA (PRWEB) March 19, 2014

AttorneyOne.com, a recognized authority on law, updated the website recently and now, can actively provide an expert opinion in view of the recent news on Pradaxa lawsuits and potential Pradaxa Class Action lawsuit.

According to a Court Order filed in March 13, new sanctions were imposed on Boehringer Ingelheim for Pradaxa Multidistrict Litigation discovery abuses (MDL No. 2385, U.S. District Court, Southern District of Illinois). Pradaxa, manufactured by Boehringer Ingelheim Pharmaceuticals, is a new oral anticoagulant mainly used as a blood thinner for patients who are at risk for stroke or atrial fibrillation. Boehringer Ingelheim is ordered to pay expenses related to renting offices in Amsterdam for the plaintiffs' attorneys who will travel to Europe during the deposition phase.

As Reuters reported on February 19, the process of hearing cases on Pradaxa lawsuits is scheduled to start in August. As mentioned in the article “Boehringer is facing more than 2,000 lawsuits in the United States over claims that the blockbuster drug, the first in a new class of stroke prevention pills, caused severe and fatal bleeding.”

Taking into consideration the latest developments, AttorneyOne.com updated the website and, now, can actively provide an expert opinion including how to get in contact with legal counsel easily and inexpensively in cases of severe complications, allegedly from Pradaxa. Sean Burke, director of Media Relations at AttorneyOne.com, adds that the relevant information illustrates that people continue to file Pradaxa lawsuits. "For that reason", he continues, "our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”

Bloomberg reported on February 26 that, according to unsealed court filings, Boehringer didn’t share with the FDA an analysis showing a higher death rate from Pradaxa bleeding. According to Bloomberg, the company “didn’t disclose a data analysis to U.S. regulators that indicated the blood-thinner Pradaxa may have caused more fatal bleeding after it was cleared for sale than the drug did in a study used to win approval.”

AttorneyOne.com has further information on Pradaxa lawsuits including how to get in contact with legal counsel.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2014/03/prweb11678431.htm